ACE2 and diabetes mellitus: Based on our hypothesis14, an upregulation of ACE2, due to its non-enzymatic glycation, together with a variation of the protein tertiary structure due to the aforementioned aminoacidic modifications, was suggested as a pathogenetic mechanism of SARS-CoV-2 negative outcome in diabetes mellitus.